Back
Lumos Pharma Vs. Perspective Therapeutics Industry Stock Comparison
Sell
48
LUMO
Lumos Pharma
Last Price:
3.65
Seasonality Move:
-0.8%
Sell
30
CATX
Perspective Therapeutics
Last Price:
13.23
Seasonality Move:
-10.27%
Sell
48
Lumos Pharma (LUMO)
is a Sell
Is Lumos Pharma a Buy, Sell or Hold?
- The current Lumos Pharma [LUMO] share price is $3.67. The Score for LUMO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- LUMO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.21. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LUMO Stock Price Chart
What is Lumos Pharma's stock price today?
-
The Lumos Pharma share price today is $3.67
The current trend is moderately bearish and LUMO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LUMO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 51.08 | Buy |
| Chaikin Money Flow: | 5843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.68 - 3.96) | Sell |
| Bollinger Bands (100): | (1.85 - 3.47) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 47.28 | Sell |
| Chaikin Money Flow: | 737025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.73 - 15.41) | Sell |
| Bollinger Bands (100): | (11.43 - 15.17) | Sell |
LUMO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.83 | Sell |
| 20-day SMA: | 3.8 | Sell |
| 50-day SMA: | 3.11 | Buy |
| 200-day SMA: | 2.79 | Buy |
| 8-day EMA: | 3.79 | Sell |
| 20-day EMA: | 3.73 | Sell |
| 50-day EMA: | 3.31 | Buy |
| 200-day EMA: | 2.96 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.59 | Buy |
| 20-day SMA: | 13.8 | Sell |
| 50-day SMA: | 13.77 | Sell |
| 200-day SMA: | 11.72 | Buy |
| 8-day EMA: | 12.93 | Buy |
| 20-day EMA: | 13.41 | Sell |
| 50-day EMA: | 13.57 | Sell |
| 200-day EMA: | 11.6 | Buy |
Lumos Pharma Earnings Growth & LUMO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $1.41 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Lumos Pharma Technical Analysis
| Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||